-
1
-
-
49949152277
-
-
Robert Koch-Institut und Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg). Berlin
-
Krebs in Deutschland 2003-2004. Häufigkeiten und Trends. 6. überarbeitete Auflage. Robert Koch-Institut und Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg). Berlin, 2008.
-
(2008)
Krebs in Deutschland 2003-2004. Häufigkeiten und Trends. 6. Überarbeitete Auflage
-
-
-
3
-
-
34250807116
-
Evidenzbasierte Komplementäronkologie - Aktuelle Studien und Ausblick
-
Beuth J: Evidenzbasierte Komplementäronkologie - Aktuelle Studien und Ausblick. Der Onkologe 13: 534-542, 2007.
-
(2007)
Der Onkologe
, vol.13
, pp. 534-542
-
-
Beuth, J.1
-
4
-
-
33645805238
-
Quality of life is improved in breast cancer patients by standardised mistletoe extract PS76A2 during chemotherapy and follow-up: A randomised, placebo-controlled, double-blind, multicentre clinical trial
-
Semiglazov VF, Stepula VV, Dudov A, Schnitker J and Mengs U: Quality of life is improved in breast cancer patients by standardised mistletoe extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res 26: 1519-1530, 2006.
-
(2006)
Anticancer Res
, vol.26
, pp. 1519-1530
-
-
Semiglazov, V.F.1
Stepula, V.V.2
Dudov, A.3
Schnitker, J.4
Mengs, U.5
-
5
-
-
0242277975
-
Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study
-
Schumacher K, Schneider B, Reich G, Stiefel T, Stall G, Bock PR, Hanisch J and Beuth J: Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study. Anticancer Res 23: 5081-5088, 2003.
-
(2003)
Anticancer Res
, vol.23
, pp. 5081-5088
-
-
Schumacher, K.1
Schneider, B.2
Reich, G.3
Stiefel, T.4
Stall, G.5
Bock, P.R.6
Hanisch, J.7
Beuth, J.8
-
6
-
-
40549134157
-
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: A controlled multicenter comparative epidemiological cohort study
-
Beuth J, Schneider B and Schierholz JM: Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: A controlled multicenter comparative epidemiological cohort study. Anticancer Res 28: 523-528, 2008.
-
(2008)
Anticancer Res
, vol.28
, pp. 523-528
-
-
Beuth, J.1
Schneider, B.2
Schierholz, J.M.3
-
7
-
-
0026578978
-
Developmental and maturational changes in human blood lymphocyte subpopulations
-
Hannet I, Erkeller-Yuksel F, Peter Lydyard P, Deneys V, DeBruère M: Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 13: 215-218, 1992.
-
(1992)
Immunol Today
, vol.13
, pp. 215-218
-
-
Hannet, I.1
Erkeller-Yuksel, F.2
Peter Lydyard, P.3
Deneys, V.4
Debruère, M.5
-
8
-
-
0033695704
-
Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy
-
Murta EF, de Andrade JM, Falcão RP and Bighetti S: Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumori 5: 403-407, 2000.
-
(2000)
Tumori
, vol.5
, pp. 403-407
-
-
Murta, E.F.1
De Andrade, J.M.2
Falcão, R.P.3
Bighetti, S.4
-
10
-
-
0027303146
-
Stress and immunity in humans: A meta-analytic review
-
Herbert TB and Cohen S: Stress and immunity in humans: a meta-analytic review. Psychosom Med 55: 364-379, 1993.
-
(1993)
Psychosom Med
, vol.55
, pp. 364-379
-
-
Herbert, T.B.1
Cohen, S.2
-
11
-
-
4544376367
-
Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy?
-
Sabbioni MEE, Bernhard J, Siegrist HP, Schmitz SFH, Gertsch MC, Thuerlimann B, Bonnefoi H Perey L, Herrmann R, Goldhirsch A and Huerny C: Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy? Breast Cancer Res Treatm 87: 75-86, 2004.
-
(2004)
Breast Cancer Res Treatm
, vol.87
, pp. 75-86
-
-
Sabbioni, M.E.E.1
Bernhard, J.2
Siegrist, H.P.3
Schmitz, S.F.H.4
Gertsch, M.C.5
Thuerlimann, B.6
Bonnefoi, H.7
Perey, L.8
Herrmann, R.9
Goldhirsch, A.10
Huerny, C.11
-
12
-
-
0032893529
-
Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients
-
DOI 10.1007/s005200050245
-
Sabbioni MEE, Castiglione M, Huerny C, Siegrist HP, Bacchi M, Bernhard J, Thuerlimann B, Bonnefoi H, Perey L, Goldhirsch A and Senn HJ: Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients. Supp Care Cancer 7: 149-153, 1999. (Pubitemid 29187562)
-
(1999)
Supportive Care in Cancer
, vol.7
, Issue.3
, pp. 149-153
-
-
Sabbioni, M.E.E.1
Castiglione, M.2
Hurny, C.3
Siegrist, H.-P.4
Bacchi, M.5
Bernhard, J.6
Thurlimann, B.7
Bonnefoi, H.8
Perey, L.9
Goldhirsch, A.10
Senn, H.-J.11
-
13
-
-
0018407439
-
Nutrition, immunity, and cancer-a review. Part I: Influence of protein or protein-calorie malnutrition and zinc deficiency on immunity
-
Good RA and Fernandes G: Nutrition, immunity, and cancer-a review. Part I: Influence of protein or protein-calorie malnutrition and zinc deficiency on immunity. Clin Bull 8: 3-12, 1979.
-
(1979)
Clin Bull
, vol.8
, pp. 3-12
-
-
Good, R.A.1
Fernandes, G.2
-
14
-
-
0038307758
-
Immunomodulation in cancer therapeutics
-
Ehrke MJ: Immunomodulation in cancer therapeutics. Int Immunopharmacol 3: 1105-1119, 2003.
-
(2003)
Int Immunopharmacol
, vol.3
, pp. 1105-1119
-
-
Ehrke, M.J.1
-
15
-
-
0032873140
-
Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer
-
DOI 10.2165/00003088-199937030-00002
-
Danesi R, Conte PF and Del Tacca M: Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer. Clin Pharmacokin 37: 195-211, 1999. (Pubitemid 29452755)
-
(1999)
Clinical Pharmacokinetics
, vol.37
, Issue.3
, pp. 195-211
-
-
Danesi, R.1
Conte, P.F.2
Del Tacca, M.3
-
16
-
-
0022447001
-
Augmentation of the generation of cell-mediated cytotoxicity after a single dose of adriamycin in cancer patients
-
Arinaga S, Akiyoshi T and Tsuji H: Augmentation of the generation of cell-mediated cytotoxicity after a single dose of adriamycin in cancer patients. Cancer Res 46: 4213-4216, 1986.
-
(1986)
Cancer Res
, vol.46
, pp. 4213-4216
-
-
Arinaga, S.1
Akiyoshi, T.2
Tsuji, H.3
-
17
-
-
0034666250
-
Docetaxel-induced lymphopenia in patients with solid tumors: A prospective phenotypic analysis
-
Kotsakis A, Sarra E, Peraki M, Koukourakis M, Apostolaki S, Souglakos J, Mavromanomakis E, Vlachonikolis J and Georgoulias V: Docetaxel-induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis. Cancer 89: 1380-1386, 2000.
-
(2000)
Cancer
, vol.89
, pp. 1380-1386
-
-
Kotsakis, A.1
Sarra, E.2
Peraki, M.3
Koukourakis, M.4
Apostolaki, S.5
Souglakos, J.6
Mavromanomakis, E.7
Vlachonikolis, J.8
Georgoulias, V.9
-
19
-
-
0031889918
-
Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro
-
Grünberg E, Eckert K and Maurer HR: Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro. Int J Oncol 12: 957-963, 1998. (Pubitemid 28133593)
-
(1998)
International Journal of Oncology
, vol.12
, Issue.4
, pp. 957-963
-
-
Grunberg, E.1
Eckert, K.2
Maurer, H.R.3
|